Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
97.916,61
-0,77%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TC BioPharm Holdings PLC (TCBP) TC BioPharm Holdings PLC (TCBP) Notizie

TC BioPharm Holdings PLC

TCBP
0,649
0,013 (2,04%)
24 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/12/202414:30PRNUSTCBP Advances ACHIEVE Phase 2b Clinical Trial with Final..
18/12/202414:30PRNUSTCBP Announces General Meeting of Shareholders to Approve..
11/12/202413:00PRNUSTCBP Partners with CareDx to Support ACHIEVE Clinical Trial..
04/12/202414:30PRNUSTCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical..
12/11/202415:30PRNUSTCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant
30/10/202413:30PRNUSTCBP Provides Shareholder Update and Highlights Recent..
25/10/202415:45PRNUSTCBP Responds to False Social Media Claim
22/10/202419:45APSBiotech Shares Rip Following Collaboration Announcement For..
22/10/202414:30PRNUSTCBP Enters Research Planning Collaboration with Dr. Carlos..
03/10/202414:30PRNUSTCBP Announces Artificial Intelligence Initiative with..
25/9/202414:30PRNUSTCBP Announces Site Opening of Guys and St. Thomas Hospital
24/9/202414:45PRNUSTCBP to Present at the 2024 ThinkEquity Conference in NYC
20/9/202422:00PRNUS/C O R R E C T I O N -- TC BioPharm/
12/9/202414:30PRNUSTCBP Announces First Patient Completed the Full Fose Regimen..
09/9/202414:30PRNUSTC BioPharm Intends to Launch Preclinical Studies for..
06/9/202422:00PRNUSTC BioPharm Intends to Launch Preclinical Studies for..
05/9/202414:30PRNUSTCBP Announces Participation at the H.C. Wainwright 26th..
03/9/202414:30PRNUSTCBP Announces Dosing of 5 New Patients in ACHIEVE
30/8/202421:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202423:11EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
29/8/202400:32EDGAR2Form F-1MEF - Registration statement to add securities to..
28/8/202423:15PRNUSTC BioPharm Announces Closing of Upsized $6.0 Million Public..
28/8/202419:50PRNUSTC BioPharm Announces Grant of European Patent Covering Use..
23/8/202423:30EDGAR2Form F-1/A - Registration statement for certain foreign..
23/8/202422:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/8/202422:20EDGAR2Form F-1 - Registration statement for certain foreign..
15/8/202419:00PRNUSTC BioPharm Regains Compliance with Nasdaq Listing Rule..
15/8/202417:30PRNUSTC BioPharm Announces Closing of $2.0 Million Public..
15/8/202416:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/8/202413:30EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
13/8/202422:30PRNUSTC BioPharm Announces Pricing of $2.0 Registered Direct..
13/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
08/8/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/8/202422:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/7/202414:00PRNUSTCBP Announces Plan to Implement ADS Ratio Change
29/7/202422:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/7/202414:00PRNUSTCBP Announces Dosing of 6th Patient in ACHIEVE Study in..
15/5/202414:30PRNUSTCBP Announces Launch of Compassionate Use Program for..
06/5/202419:01PRNUSTC BioPharm Announces Exercise of Warrants for £3.1 Million..
06/5/202414:30PRNUSTC BioPharm Announces Execution of Second Non-Binding Letter..
04/4/202414:32PRNUSTCBP Announces Execution of Non-Binding Letter of Intent for..
02/4/202414:30PRNUSTCBP Increasing Treatment Capacity with Expanded..
19/3/202413:30PRNUSTCBP Adjourns General Meeting Until a Later Date
18/3/202413:30PRNUSTCBP Announces Exercise of Series D Warrants For Cash
06/3/202412:30EDGAR2Form 8-K - Current report
01/3/202414:30PRNUSBryan Kobel, CEO of TCBP, Appears on Nationally Syndicated..
27/2/202423:15PRNUS/C O R R E C T I O N -- TC BioPharm/
27/2/202414:30PRNUSTCBP Announces Shareholder Update Call on March 5th 2024
22/2/202415:32PRNUSTCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK..
20/2/202412:05EDGAR2Form DEF 14A - Other definitive proxy statements
Apertura: 0,6378 Min: 0,62 Max: 0,80
Chiusura: 0,636

La tua Cronologia

NASDAQ
TCBP
TC BioPharm
BIT
UC0JN1
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network